Diagonal Bio is a dynamic and innovative company that develops a groundbreaking platform technology for ultra-fast, easy-to-use, and accurate detection of genetic markers.
The company was founded at the onset of the covid-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases. Diagonal Bio’s team is led by experienced professionals in the biotechnology field, including COB Kerstin Jakobsson, interim CEO Karin Wehlin, CFO Per Heander, and a diverse board of directors.
Diagonal's operations are based in Lund, Sweden and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden) and Kushagr Punyani (Spermosens AB).
www.diagonalbio.com
Company Details
- Employees
- 11
- Founded
- -
- Address
- Medicon Village, Lund,sweden
- Industry
- Biotechnology
- Website
- diagonalpharma.com
- Keywords
- Respiratorius AB.
- HQ
- Lund
Diagonal Bio Questions
Diagonal Bio's website is diagonalpharma.com
Diagonal Bio's LinkedIn profile is https://se.linkedin.com/company/diagonal-bio
Diagonal Bio has
11 employees.
View email and phone details for 11
employees at Diagonal Bio.
Diagonal Bio's industry is
Biotechnology
Diagonal Bio's top competitors are
Swiss Nordic,
Nested Bio Ab,
Navia Corporate Finance,
Sorbus Biomedical,
Frog,
Impala Nordic,
Respiratorius Ab,
Dahlfelt Consulting Aps,
Prolevi Bio,
Spermosens Ab.
Diagonal Bio's categories are Biotechnology
Diagonal Bio's founding year is 2020
